Kazia Therapeutics Limited American Depositary Shares (KZIA) News

Latest headlines that mention KZIA, newest first · each headline opens the original publisher

KZIA quote

Last price: $7.87
Day change: +0.77%
Next earnings: —

Quote & chart Expected move Insider trading IV rank history

KZIA headlines

latest coverage

Seeking Alpha 5d ago

Kazia gains as Guggenheim is latest to initiate at Buy on lead asset

General T2KZIA

Investing.com 7d ago

Leerink initiates Kazia Therapeutics stock with $30 target

General T3KZIA

Seeking Alpha News 1mo ago

Kazia Therapeutics Limited (KZIA) Discusses Clinical and Corporate Updates With Focus on Paxalisib Programs in Breast and Colorectal Cancer - Slideshow

General T2KZIA

Yahoo Finance 1mo ago

Kazia (KZIA) Raises Approximately $40M in Gross Proceeds and Expands Paxalisib. Is the Capital Base Stronger than the Clinical Evidence?

General T2KZIA

Seeking Alpha News 1mo ago

Kazia Therapeutics Limited (KZIA) Discusses Clinical and Corporate Updates With Focus on Paxalisib Programs in Breast and Colorectal Cancer Transcript

General T2KZIA

Seeking Alpha News 1mo ago

Kazia Therapeutics: Worth Speculating On Paxalisib's TNBC Data

General T2KZIA

Investing.com 2mo ago

Kazia Therapeutics prices $40 million public offering

General T3KZIA

Seeking Alpha 2mo ago

Kazia Therapeutics announces proposed public offering

General T2KZIA

Seeking Alpha News 2mo ago

Kazia Therapeutics: Upcoming Data May Validate Best-In-Class Potential Of Paxalisib

General T2KZIA

KZIA news alerts

Get an alert by email or push when a new headline mentions KZIA.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.